Cargando…
Metabolic heterogeneity signature of primary treatment-naïve prostate cancer
To avoid over- or under-treatment of primary prostate tumours, there is a critical need for molecular signatures to discriminate indolent from aggressive, lethal disease. Reprogrammed energy metabolism is an important hallmark of cancer, and abnormal metabolic characteristics of cancers have been im...
Autores principales: | Lin, Dong, Ettinger, Susan L., Qu, Sifeng, Xue, Hui, Nabavi, Noushin, Chuen Choi, Stephen Yiu, Bell, Robert H., Mo, Fan, Haegert, Anne M., Gout, Peter W., Fleshner, Neil, Gleave, Martin E., Pollak, Michael, Collins, Colin C., Wang, Yuzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432227/ https://www.ncbi.nlm.nih.gov/pubmed/28460430 http://dx.doi.org/10.18632/oncotarget.15237 |
Ejemplares similares
-
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer
por: Choi, Stephen Yiu Chuen, et al.
Publicado: (2018) -
Aneustat (OMN54) has aerobic glycolysis‐inhibitory activity and also immunomodulatory activity as indicated by a first‐generation PDX prostate cancer model
por: Qu, Sifeng, et al.
Publicado: (2018) -
Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts
por: Nabavi, Noushin, et al.
Publicado: (2018) -
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
por: Choi, Stephen Yiu Chuen, et al.
Publicado: (2013) -
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
por: Nabavi, Noushin, et al.
Publicado: (2017)